Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 39.10
0.00 (0.00%)
At close: Mar 13, 2026
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 603.01 million as of March 13, 2026. Its market cap has decreased by -16.81% in one year.
Market Cap
603.01M
Enterprise Value
516.53M
Revenue
176.50M
Ranking
n/a
PE Ratio
45.49
Stock Price
39.10
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 603.01M, an increase of 108.21%. That is a compound annual growth rate of 8.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 603.01M | -30.67% |
| Dec 30, 2025 | 869.82M | 43.88% |
| Dec 30, 2024 | 604.56M | -5.54% |
| Dec 29, 2023 | 640.03M | 1.22% |
| Dec 30, 2022 | 632.32M | -43.06% |
| Dec 30, 2021 | 1.11B | 32.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.77B |
| Nordhealth AS | 2.18B |
| Photocure ASA | 1.80B |
| Thor Medical ASA | 1.69B |
| ArcticZymes Technologies ASA | 1.10B |
| Nykode Therapeutics AS | 969.84M |
| Vistin Pharma ASA | 957.84M |
| Omda AS | 840.81M |